30 Recruiting Lupus Nephritis Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceTop Recruiting Lupus Nephritis Studies
A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
📍 Nkarta Investigational Site — Little Rock, Arkansas
View Study & Checklist ➔The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
📍 AKDHC Medical Research ServicesLLC — Phoenix, Arizona
View Study & Checklist ➔A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
📍 Wallace Rheumatic Studies Center — Beverly Hills, California
View Study & Checklist ➔US Zamto-cel Autoimmune Diseases
📍 Froedtert Hospital and the Medical College of Wisconsin — Milwaukee, Wisconsin
View Study & Checklist ➔Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial
📍 AARA Clinical Research — Glendale, Arizona
View Study & Checklist ➔PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
📍 Purushotham & Akther Kotha MD, Inc. — La Mesa, California
View Study & Checklist ➔Daratumumab to Treat Active Lupus Nephritis
📍 Mayo Clinic in Rochester — Rochester, Minnesota
View Study & Checklist ➔A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV Lupus Nephritis
📍 University of Alabama at Birmingham Medical Center — Birmingham, Alabama
View Study & Checklist ➔A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
📍 Loma Linda University health — Loma Linda, California
View Study & Checklist ➔Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis
📍 Research Site — Glendale, Arizona
View Study & Checklist ➔An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases
📍 Investigational Site (523) — Phoenix, Arizona
View Study & Checklist ➔Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN
📍 GSK Investigational Site — Baltimore, Maryland
View Study & Checklist ➔VIBRANT: VIB4920 for Active Lupus Nephritis
📍 University of California San Diego School of Medicine: Division of Rheumatology, Allergy and Immunology — La Jolla, California
View Study & Checklist ➔Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)
📍 Circuit Clinical — Orchard Park, New York
View Study & Checklist ➔Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis
📍 University Of Alabama — Birmingham, Alabama
View Study & Checklist ➔Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)
📍 Icahn School of Medicine at Mount Sinai — New York, New York
View Study & Checklist ➔Wellness & Workforce Solution for Lupus/Lupus Nephritis
📍 Morehouse School of Medicine — Atlanta, Georgia
View Study & Checklist ➔